Minerva Surgical Inc. (UTRS)
0.00
null (null%)
At close: Jan 13, 2025, 8:00 PM
0.00
-100.00%
After-hours Dec 31, 1969, 07:00 PM EST
undefined% (undefined)
| Bid | n/a |
| Market Cap | 888 |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -7.61 |
| PE Ratio (ttm) | 0 |
| Forward PE | n/a |
| Analyst | Buy |
| Ask | n/a |
| Volume | 140 |
| Avg. Volume (20D) | 99 |
| Open | 0.00 |
| Previous Close | undefined |
| Day's Range | 0.00 - 0.00 |
| 52-Week Range | 0.00 - 1.08 |
| Beta | undefined |
About UTRS
Minerva Surgical, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes minimally invasive solutions to meet the uterine healthcare needs of women in the United States. The company offers Minerva ES Endometrial Ablation System and Genesys HTA Endometrial Ablation System, which are endometrial ablation devices; Symphion Tissue Removal System, a minimally invasive uterine tissue removal system to combine bl...
Sector Healthcare
IPO Date Oct 22, 2021
Employees 174
Stock Exchange NASDAQ
Ticker Symbol UTRS
Website https://minervasurgical.com
Analyst Forecast
According to 1 analyst ratings, the average rating for UTRS stock is "Buy." The 12-month stock price forecast is $undefined, which is a decrease of NaN% from the latest price.
Buy 100.00%
Hold 0.00%
Sell 0.00%
